Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 784
Ph III recruiting: 82
Growth YoY: +24.4%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 501–508 of 508 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00215709	Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer	completed	Phase 1	17	Geriatric Oncology ConsortiumOTHER	1	Nov 19, 2007	clinicaltrials
NCT00115635	Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer	completed	Phase 1 / Phase 2	60	Herlev HospitalOTHER	1	Oct 2, 2007	clinicaltrials